Compound Detail
CHEMBL452861
LEVOPROPRANOLOL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL452861 |
| Name | LEVOPROPRANOLOL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | AQHHHDLHHXJYJD-AWEZNQCLSA-N |
21
Targets
46
Activities
4
Assay Types
6
PK Parameters
20
Publications
3
Known Names
Molecular Properties
259.4
MW (Da)
2.58
ALogP
3
HBA
2
HBD
41.5
PSA (Ų)
0.84
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
Ki 23 meas. best 9.61
IC50 20 meas. best 9.45
EC50 2 meas. best 8.74
Kd 1 meas. best 9.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 9.61 | 9.44 | 0.2 | 2 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 9.45 | 9.28 | 0.4 | 2 |
| Adrenergic receptor beta CHEMBL2095166 | Kd | 9.15 | 9.15 | 0.7 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 8.96 | 8.905 | 1.1 | 2 |
| Beta-1 adrenergic receptor CHEMBL213 | EC50 | 8.74 | 8.74 | 1.8 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 8.72 | 8.66 | 1.9 | 2 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | Ki | 7.77 | 7.535 | 17.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 7.26 | 7.1167 | 55.0 | 3 |
| Beta-3 adrenergic receptor CHEMBL246 | Ki | 6.91 | 6.91 | 124.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 6.91 | 6.91 | 124.0 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | IC50 | 6.78 | 6.78 | 165.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.58 | 6.58 | 262.0 | 1 |
| Serotonin 1 (5-HT1) receptor CHEMBL2095159 | Ki | 6.52 | 6.52 | 300.0 | 1 |
| Cytochrome P450 2D26 CHEMBL2483 | IC50 | 6.46 | 6.46 | 350.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 6.39 | 6.39 | 411.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 6.33 | 6.33 | 463.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 6.27 | 6.27 | 538.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 6.18 | 6.18 | 659.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 6.14 | 5.995 | 716.0 | 2 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 6.0 | 6.0 | 998.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 5.91 | 5.91 | 1241.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 5.86 | 5.86 | 1368.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 5.72 | 5.72 | 1883.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 5.55 | 5.55 | 2801.0 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 5.46 | 5.345 | 3500.0 | 2 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Ki | 5.39 | 5.39 | 4100.0 | 1 |
| Hepatic sodium/bile acid cotransporter CHEMBL5287 | IC50 | 5.21 | 5.21 | 6100.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 5.18 | 5.18 | 6665.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 5.09 | 5.09 | 8100.0 | 1 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2096682 | IC50 | 4.89 | 4.89 | 13000.0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 CHEMBL1961788 | EC50 | 4.14 | 4.14 | 72000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 214.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 51.3 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 41.4 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 12.9 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.14 | - | Not specified |
| Fu | 0.915 | - | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23403082 | 10.1016/j.bmcl.2013.01.025 | Beta-1 adrenergic receptor | 3 |
| 23403082 | 10.1016/j.bmcl.2013.01.025 | Beta-2 adrenergic receptor | 3 |
| 21998403 | 10.1124/dmd.111.042309 | ADMET | 3 |
| 3543362 | 10.1021/jm00384a001 | Serotonin 2 (5-HT2) receptor | 3 |
| 34115934 | 10.1021/acs.jmedchem.1c00733 | Nuclear receptor subfamily 2 group E member 1 | 2 |
| 12477351 | 10.1021/jm020941h | ATP-dependent translocase ABCB1 | 2 |
| 2836587 | 10.1021/jm00401a004 | Beta-2 adrenergic receptor | 2 |
| 21998403 | 10.1124/dmd.111.042309 | No relevant target | 2 |
| 2579237 | 10.1021/jm00381a019 | Sodium channel alpha subunits; brain (Types I, II, III) | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| 6120233 | 10.1021/jm00142a017 | Adrenergic receptor beta | 1 |
| 12502361 | 10.1021/jm0209578 | Cytochrome P450 2D6 | 1 |
| 12502361 | 10.1021/jm0209578 | Cytochrome P450 2D3 | 1 |
| 12502361 | 10.1021/jm0209578 | Cytochrome P450 2D26 | 1 |
| 12502361 | 10.1021/jm0209578 | Cytochrome P450 2D1 | 1 |
| 3543362 | 10.1021/jm00384a001 | 5-hydroxytryptamine receptor 2C | 1 |
| 3543362 | 10.1021/jm00384a001 | 5-hydroxytryptamine receptor 1B | 1 |
| 3543362 | 10.1021/jm00384a001 | 5-hydroxytryptamine receptor 1A | 1 |
| 2539480 | 10.1021/jm00124a021 | Adrenergic receptor beta | 1 |
Data from ChEMBL 36 via Core Engine